STOCK TITAN

Shareholders at Select Medical (NYSE: SEM) back declassified board and 25% meeting right

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Select Medical Holdings Corporation reported results of its annual stockholder meeting. Stockholders elected three Class II directors, each receiving over 111.6 million votes in favor, and approved a non-binding advisory vote on executive compensation with 110.7 million votes for.

Stockholders ratified PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 116.3 million votes for. They approved an amendment to phase out the classified structure of the board of directors, supported by 113.8 million votes. A company proposal to give stockholders the right to call special meetings at a 25% ownership threshold received 96.4 million votes for, while a separate shareholder proposal for a 10% threshold drew 22.8 million votes for and was not approved.

Positive

  • None.

Negative

  • None.
Item 5.07 Submission of Matters to a Vote of Security Holders Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Votes for Ortenzio 111,618,633 votes Election of Class II director Robert A. Ortenzio
Votes for say-on-pay 110,664,208 votes Non-binding advisory vote on executive compensation
Votes for auditor ratification 116,286,685 votes Ratification of PricewaterhouseCoopers LLP for fiscal year ending December 31, 2026
Votes for declassification amendment 113,798,371 votes Amendment to phase out classified board structure
Votes for 25% special meeting right 96,440,477 votes Company proposal for stockholder right to call special meetings at 25% threshold
Votes for 10% special meeting right 22,780,354 votes Shareholder proposal for stockholder right to call special meetings at 10% threshold
classified structure of the board of directors financial
"Approval of amendment to phase out the classified structure of the board of directors"
non-binding advisory vote financial
"Non-Binding Advisory Vote on the Compensation of the Company’s Named Executive Officers"
A non-binding advisory vote is a shareholder vote that expresses investors’ opinion on a proposal (such as executive pay, corporate policy, or governance practices) but does not legally force the company to act. Think of it like a customer survey: it signals whether owners approve or disapprove and can pressure boards and managers to change course, so investors watch the result as an indicator of governance risk and potential future shifts in company strategy or leadership.
broker non-votes financial
"Votes For, Votes Against, Abstentions, Broker Non-Votes"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
independent registered public accounting firm financial
"Appointment of PricewaterhouseCoopers LLP as the Company’s Independent Registered Public Accounting Firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
Amended and Restated Certificate of Incorporation financial
"Approval of Amendment to the Company’s Amended and Restated Certificate of Incorporation"
A company’s amended and restated certificate of incorporation is an updated version of its foundational legal charter that replaces the older document and folds in all changes into one clear copy; it spells out corporate structure, classes of stock, shareholder rights and key governance rules. Investors care because it can change who controls the company, how votes are counted, what claims shareholders have on assets or dividends, and can introduce or remove protections against takeovers—like updating a house title after a major renovation to show who owns what and under what rules.
ownership threshold financial
"Right to Call a Special Meeting of Stockholders at a 25% Ownership Threshold"
false 0001320414 false 0001320414 2026-04-23 2026-04-23 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

 

FORM 8-K

 

current report

 

Pursuant to Section 13 or 15(d) of the

 

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): April 23, 2026

 

 

 

SELECT MEDICAL HOLDINGS CORPORATION

 

 

(Exact name of registrant as specified in its charter)

 

Delaware  001-34465  20-1764048
(State or other jurisdiction of
Incorporation)
  (Commission File
Number)
  (I.R.S. Employer
Identification No.)

 

 

 

4714 Gettysburg Road, P.O. Box 2034

Mechanicsburg, PA 17055

(Address of principal executive offices)  (Zip Code)

 

(717) 972-1100

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.001 per share SEM New York Stock Exchange (NYSE)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether either registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if either registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 5.07Submission of Matters to a Vote of Security Holders.

 

The annual meeting of stockholders (the “Annual Meeting”) of Select Medical Holdings Corporation (the “Company”) was held on April 23, 2026. At the Annual Meeting, the Company’s stockholders approved five proposals. The proposals below are described in the Company’s definitive proxy statement dated March 4, 2026. The results are as follows:

 

Proposal 1: The Election of Three Class II Directors to the Board of Directors

 

Name  Votes For   Votes Against   Abstentions   Broker Non-Votes 
Robert A. Ortenzio   111,618,633    2,388,573    30,199    3,812,633 
Daniel J. Thomas   112,624,578    1,382,053    30,774    3,812,633 
Parvinderjit S. Khanuja   113,275,867    731,003    30,535    3,812,633 

 

Proposal 2: Non-Binding Advisory Vote on the Compensation of the Company’s Named Executive Officers

 

Votes For   Votes Against   Abstentions   Broker Non-Votes 
 110,664,208    3,339,567    33,630    3,812,633 

 

Proposal 3: Ratification of the Appointment of PricewaterhouseCoopers LLP as the Company’s Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2026

 

Votes For   Votes Against   Abstentions   Broker Non-Votes 
 116,286,685    1,534,942    28,411    0 

 

Proposal 4: Approval of Amendment to the Company’s Amended and Restated Certificate of Incorporation to Phase Out the Classified Structure of the Board of Directors

 

Votes For   Votes Against   Abstentions   Broker Non-Votes 
 113,798,371    233,759    5,275    3,812,633 

 

Proposal 5: Non-Binding Advisory Vote on Company Proposal to Provide Stockholders the Right to Call a Special Meeting of Stockholders at a 25% Ownership Threshold

 

Votes For   Votes Against   Abstentions   Broker Non-Votes 
 96,440,477    13,333,066    4,263,862    3,812,633 

 

Proposal 6: Non-Binding Advisory Vote on Shareholder Proposal to Provide Stockholders the Right to Call a Special Meeting of Stockholders at a 10% Ownership Threshold

 

Votes For   Votes Against   Abstentions   Broker Non-Votes 
 22,780,354    91,191,886    65,165    3,812,633 

 

Item 9.01 Financial Statements and Exhibits.  

 

(d) Exhibits.

 

Exhibit

No.

Description
   
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  SELECT MEDICAL HOLDINGS CORPORATION
   
Date: April 24, 2026 By: /s/ John F. Duggan
    John F. Duggan 
    Executive Vice President, General Counsel and Secretary

 

 

FAQ

What did Select Medical (SEM) stockholders decide at the 2026 annual meeting?

Stockholders elected three Class II directors, approved executive compensation on an advisory basis, ratified PricewaterhouseCoopers LLP as auditor, backed phasing out the classified board, and supported a 25% special meeting right while not approving a 10% special meeting threshold.

Were Select Medical (SEM) director nominees re-elected at the 2026 annual meeting?

Yes. All three Class II director nominees were elected. Robert A. Ortenzio received 111,618,633 votes for, Daniel J. Thomas received 112,624,578 votes for, and Parvinderjit S. Khanuja received 113,275,867 votes for, with relatively low opposition and broker non-votes reported.

How did Select Medical (SEM) stockholders vote on executive compensation in 2026?

Stockholders approved the non-binding advisory resolution on named executive officer compensation. The proposal received 110,664,208 votes for, 3,339,567 votes against, and 33,630 abstentions, with 3,812,633 broker non-votes, indicating overall support for the company’s pay practices.

Did Select Medical (SEM) stockholders approve the auditor for fiscal 2026?

Yes. Stockholders ratified PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, with 116,286,685 votes for, 1,534,942 votes against, and 28,411 abstentions, and no broker non-votes reported on this item.

What corporate governance changes did Select Medical (SEM) stockholders support?

Stockholders approved amending the certificate of incorporation to phase out the classified board, with 113,798,371 votes for. They also backed a company proposal giving stockholders the right to call special meetings at a 25% ownership threshold, while not approving a separate 10% threshold shareholder proposal.

How did Select Medical (SEM) investors vote on special meeting rights proposals?

A company proposal for a 25% ownership threshold to call special meetings received 96,440,477 votes for, 13,333,066 against, and 4,263,862 abstentions. A separate shareholder proposal for a 10% threshold received 22,780,354 votes for and 91,191,886 votes against, so it was not approved.

Filing Exhibits & Attachments

3 documents